Saudi VAT on Medicines and Medical Equipment: Article 35

Article 35 zero-rates qualifying medicines and medical goods according to the competent classifications. It does not zero-rate every product sold in a pharmacy, everything used by a hospital or every service associated with medical equipment. Match the particular product and supply to the current official classification and retain the evidence.

Apply the competent classification to the particular product

Article 35(1)–(2), p. 34, links zero-rating to qualifying medicines/medical goods and classifications issued by the Ministry of Health or another competent Saudi authority, subject to the stated GCC health-minister controls.

ZATCA’s Healthcare Sector guideline, second edition May 2026, section 6, p. 29, describes the adopted SFDA categories. It distinguishes locally manufactured pharmaceutical/health preparations and qualifying imported preparations with SFDA clearance, and registered medical devices/products with the relevant local manufacture or import-clearance conditions.

Do not collapse these descriptions into a rule that every vitamin, herbal product or unregistered device is zero-rated. Establish which category applies and its conditions. Product name, marketing claims, medical use and tariff classification alone can leave essential qualification facts unanswered.

Keep current product and clearance evidence

Section 6.1, pp. 29–30, makes the supplier responsible for identifying qualifying goods and supporting its treatment. Retain the product identity/registration or other applicable classification, relevant clearance for imports, the competent determination and the version/date used.

The SFDA Drugs List is an official product-information starting point. A generic product-list entry or retail price should not be presented as a separate blanket VAT ruling for every pack, device or related service. Use the applicable classification and actual goods.

Dariba recommendation: maintain product-level tax evidence in the stock master and review new/changed products before assigning the rate. A historic distributor spreadsheet is a research aid; it does not replace the current competent classification where facts or status change.

Zero-rating can follow the goods through the supply chain

Section 6.1 explains that qualifying supplies by taxable manufacturers, importers, distributors, healthcare institutions, pharmacies, retailers and suppliers of used medical goods can be zero-rated. The final recipient need not have a prescription or prove a particular medical use merely to preserve an already qualifying good’s classification.

This is different from saying every seller is required to charge VAT irrespective of registration/economic-activity rules. Nor does a used device qualify solely because it was previously in a hospital: establish that the actual goods meet the competent classification.

Dariba analysis: preserve the same product identity across the chain while evaluating each transaction. Independent maintenance, installation, rental or consultancy is not automatically the same supply as a sale of qualifying goods.

Import relief does not replace customs or product requirements

Agreement Article 38 and guideline section 6.2, p. 30, provide import VAT exemption for qualifying goods whose domestic supply is zero-rated. The importer remains responsible for the correct customs treatment and supporting qualification.

Customs duties are a separate question; VAT relief does not itself waive applicable customs duties or product clearance. Likewise, duty-free treatment does not independently establish Article 35 qualification.

The import-relief guide distinguishes exemption, suspension and return accounting. There is no input credit for import VAT that was never charged, while VAT actually incurred on other eligible taxable-business costs requires its normal deduction analysis.

Separate goods from treatment services on a supported basis

Guideline section 4.2, Example 6, p. 17, distinguishes a qualifying prosthetic tooth from the dentist’s standard-rated services. Section 6 does not turn the entire treatment package into qualifying goods merely because medical equipment is essential to the procedure.

For an actual separate qualifying goods element, show the appropriate value and rate, using supported commercial pricing. Insignificant consumables absorbed in providing a service should not be inflated into an artificial zero-rated allocation.

See the healthcare-services guide for public-authority activities, private treatment and citizen State-bearing treatment. That citizen mechanism covers its specified services; goods/products retain their own statutory classification.

Consignment stock can have an earlier VAT event than title transfer

Section 6.4.1, pp. 31–32, describes stock physically held by a pharmacy/provider while legal title remains with the supplier until later notification of sale. It applies the earlier actual supply/disposal, invoice or payment rules, rather than treating retained legal title as a universal deferral.

The actual rights matter: determine when goods are placed at the recipient’s disposal and whether an invoice/payment has already created the relevant tax point. A consignment label cannot decide this for every stock arrangement.

The guideline’s phrase about issuing within “15 days from the month following” should be read with Article 53’s actual deadline, rather than converted into an invented rolling 15-day period after delivery. The invoicing guide explains the applicable document rules. Zero-rated goods still require the relevant invoice and records.

Free samples require rate and nominal-supply tests separately

Section 6.4.2, pp. 32–33, distinguishes nominal-supply conditions, low-value sample exceptions and the product’s actual VAT rate. A qualifying medicine’s nominal supply can be zero-rated; a non-qualifying promotional product can be standard-rated where the nominal-supply rules apply.

Example 12, p. 33, considers samples supplied in 2021 with overall fair market value SAR 49,000 and cost SAR 44,000. It distinguishes a non-qualifying cholesterol-testing device exceeding the individual low-value condition from the overall annual total. A below-limit annual total does not, by itself, satisfy every recipient-level condition.

The deemed-supply guide explains current Article 15 conditions and Article 39’s valuation. Do not replace fair market value for the gift-condition test with the supplier’s cost, or apply a standard rate to every sample solely because it is supplied free.

Input recovery depends on actual taxable-business use

Section 7.1, Example 13, p. 34, describes a factory buying cartons for qualifying medicines it produces. The zero output rate does not prevent deduction of VAT on otherwise eligible packaging costs.

Dariba original illustration: a taxable manufacturer incurs SAR 10,000 net plus SAR 1,500 VAT on packaging wholly used for its qualifying taxable supplies, with valid evidence and no restriction. Its input claim can be SAR 1,500 on those assumptions; it does not invent VAT on a qualifying medicine purchase that properly carried 0%.

Keep actual use, recipient, invoices, import documents and any mixed/private allocation alongside product qualification. Zero-rating the goods and claiming their associated inputs are related decisions with separate evidence requirements.